🟢 CTXR is trading 7% up today, extending its technical rebound from recent lows

CTXR is trading 7% up at $0.65 in pre-market as a technical continuation of its recent rebound from the mid-$0.50s.

• The move appears to be a technical extension of the recent bounce rather than driven by new fundamental catalysts.
• There have been no new headlines regarding earnings, FDA approvals, financing, or M&A since the May 15, 2026, Q2 report and LYMPHIR update.